Human PMP22/CIDP/CMT1A ORF/cDNA clone-Lentivirus plasmid (NM_000304)
Cat. No.: pGMLP000512
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human PMP22/CIDP/CMT1A Lentiviral expression plasmid for PMP22 lentivirus packaging, PMP22 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
PMP22/CIDP products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000512 |
| Gene Name | PMP22 |
| Accession Number | NM_000304 |
| Gene ID | 5376 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 483 bp |
| Gene Alias | CIDP,CMT1A,CMT1E,DSS,GAS-3,GAS3,HMSNIA,HNPP,Sp110 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCTCCTCCTGTTGCTGAGTATCATCGTCCTCCACGTCGCGGTGCTGGTGCTGCTGTTCGTCTCCACGATCGTCAGCCAATGGATCGTGGGCAATGGACACGCAACTGATCTCTGGCAGAACTGTAGCACCTCTTCCTCAGGAAATGTCCACCACTGTTTCTCATCATCACCAAACGAATGGCTGCAGTCTGTCCAGGCCACCATGATCCTGTCGATCATCTTCAGCATTCTGTCTCTGTTCCTGTTCTTCTGCCAACTCTTCACCCTCACCAAGGGGGGCAGGTTTTACATCACTGGAATCTTCCAAATTCTTGCTGGTCTGTGCGTGATGAGTGCTGCGGCCATCTACACGGTGAGGCACCCGGAGTGGCATCTCAACTCGGATTACTCCTACGGTTTCGCCTACATCCTGGCCTGGGTGGCCTTCCCCCTGGCCCTTCTCAGCGGTGTCATCTATGTGATCTTGCGGAAACGCGAATGA |
| ORF Protein Sequence | MLLLLLSIIVLHVAVLVLLFVSTIVSQWIVGNGHATDLWQNCSTSSSGNVHHCFSSSPNEWLQSVQATMILSIIFSILSLFLFFCQLFTLTKGGRFYITGIFQILAGLCVMSAAAIYTVRHPEWHLNSDYSYGFAYILAWVAFPLALLSGVIYVILRKRE |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-MP1395-Ab | Anti-PMP22/ CIDP/ CMT1A monoclonal antibody |
| Target Antigen | GM-Tg-g-MP1395-Ag | PMP22 VLP (virus-like particle) |
| ORF Viral Vector | pGMLP000512 | Human PMP22 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000148 | Human PMP22 Adenovirus plasmid |
| ORF Viral Vector | vGMLP000512 | Human PMP22 Lentivirus particle |
| ORF Viral Vector | vGMAP000148 | Human PMP22 Adenovirus particle |
Target information
| Target ID | GM-MP1395 |
| Target Name | PMP22 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
5376 |
| Gene ID |
100034146 (Equus caballus), 101092215 (Felis catus), 18858 (Mus musculus), 24660 (Rattus norvegicus) 479509 (Canis lupus familiaris), 534497 (Bos taurus), 5376 (Homo sapiens), 693527 (Macaca mulatta) |
| Gene Symbols & Synonyms | PMP22,Pmp22,Tr,HNPP,Gas-3,PMP-22,TRE002,trembler,DSS,CIDP,GAS3,CMT1A,CMT1E,GAS-3,Sp110,HMSNIA |
| Target Alternative Names | CIDP,CMT1A,CMT1E,DSS,GAS-3,GAS3,Gas-3,Growth arrest-specific protein 3 (GAS-3),HMSNIA,HNPP,PMP-22,PMP22,Peripheral myelin protein 22,Pmp22,Sp110,TRE002,Tr,trembler |
| Uniprot Accession |
P16646,P25094,Q01453,Q6WL85,Q9TQZ3
Additional SwissProt Accessions: Q6WL85,P16646,P25094,Q9TQZ3,Q01453 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | |
| Disease | cancer |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000025178, ENSMUSG00000018217, ENSCAFG00845004152, ENSBTAG00000019070, ENSG00000109099, ENSMMUG00000002206 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


